Antimycobacterial

This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009)

An antimycobacterial is a type of drug used to treat Mycobacteria infections.

Types include:

• Tuberculosis treatments
• Leprostatic agents

v · d · ePharmacology: major drug groups Gastrointestinal tract/metabolism (A) stomach acid (Antacids, H2 antagonists, Proton pump inhibitors) • Antiemetics • Laxatives • Antidiarrhoeals/Antipropulsives • Anti-obesity drugs • Anti-diabetics • Vitamins • Dietary minerals Blood and blood forming organs (B) Antithrombotics (Antiplatelets, Anticoagulants, Thrombolytics/fibrinolytics) • Antihemorrhagics (Platelets, Coagulants, Antifibrinolytics) Cardiovascular system (C) cardiac therapy/antianginals (Cardiac glycosides, Antiarrhythmics, Cardiac stimulants) Antihypertensives • Diuretics • Vasodilators • Beta blockers • Calcium channel blockers • renin-angiotensin system (ACE inhibitors, Angiotensin II receptor antagonists, Renin inhibitors) Antihyperlipidemics (Statins, Fibrates, Bile acid sequestrants) Skin (D) Emollients • Cicatrizants • Antipruritics • Antipsoriatics • Medicated dressings Genitourinary system (G) Hormonal contraception • Fertility agents • SERMs • Sex hormones Endocrine system (H) Hypothalamic-pituitary hormones • Corticosteroids (Glucocorticoids, Mineralocorticoids) • Sex hormones • Thyroid hormones/Antithyroid agents Infections and infestations (J, P, QI) Antimicrobials: Antibacterials (Antimycobacterials) • Antifungals • Antivirals • Antiparasitics (Antiprotozoals, Anthelmintics, Ectoparasiticides) • IVIG • Vaccines Malignant disease (L01-L02) Anticancer agents (Antimetabolites, Alkylating, Spindle poisons, Antineoplastic, Topoisomerase inhibitors) Immune disease (L03-L04) Immunomodulators (Immunostimulants, Immunosuppressants) Muscles, bones, and joints (M) Anabolic steroids • Anti-inflammatories (NSAIDs) • Antirheumatics • Corticosteroids • Muscle relaxants • Bisphosphonates Brain and nervous system (N) Analgesics • Anesthetics (General, Local) • Anorectics • Anti-ADHD Agents • Antiaddictives • Anticonvulsants • Antidementia Agents • Antidepressants • Antimigraine Agents • Antiparkinson's Agents • Antipsychotics • Anxiolytics • Depressants • Entactogens • Entheogens • Euphoriants • Hallucinogens (Psychedelics, Dissociatives, Deliriants) • Hypnotics/Sedatives • Mood Stabilizers • Neuroprotectives • Nootropics • Neurotoxins • Orexigenics • Serenics • Stimulants • Wakefulness-Promoting Agents Respiratory system (R) Decongestants • Bronchodilators • Cough medicines • H1 antagonists Sensory organs (S) Ophthalmologicals • Otologicals Other ATC (V) Antidotes • Contrast media • Radiopharmaceuticals • Dressings

v · d · eAntimycobacterials, including tuberculosis treatment and leprostatic agents (J04) Nucleic acid inhibitor Rifamycins/ RNA polymerase inhibitor Rifampicin# • Rifabutin • Rifapentine Antifolates/DSI Dapsone# • Acedapsone • Aldesulfone sodium ASA 4-Aminosalicylic acid# (Calcium aminosalicylate, Sodium aminosalicylate) Protein synthesis inhibitor Aminoglycosides Amikacin# • Capreomycin# • Kanamycin# • Streptomycin# Oxazolidone Linezolid Cell envelope antibiotic Peptidoglycan layer Alanine analogue: Cycloserine# Arabinogalactan layer Ethylenediamine/arabinosyltransferase inhibitor: Ethambutol# SQ109† Mycolic acid layer Hydrazides/mycolic acid synth. inhibition: Isoniazid# Thiocarbamides: Ethionamide# • Prothionamide • Thiocarlide Other/unknown phenazine (Clofazimine)# • pyrazine (Pyrazinamide#, Morinamide) • isoxazole (Terizidone) • R207910/TMC207† Combinations Rifampicin/isoniazid/pyrazinamide #WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III M: BAC bact (clas) gr+f/gr+a(t)/gr-p(c)/gr-o drug(J1p, w, n, m, vacc)

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.v · d · e

This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)